Global Neonatal Jaundice Treatment Market, By Type (Primary Care, Secondary Care), Technology (Light-Emitting Diode Light Sources, Fluorescent, Halogen and Fiberoptic), End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Users and Others), Distribution Channel (Direct Tender, Retail Sales and Third Party Distribution) - Industry Trends and Forecast to 2029.
Market Analysis and Insights
Advancements in the treatment of jaundice is being done as sometimes jaundice can indicate an underlying medical condition. Neonatal jaundice refers to a yellowing of the white part of the eyes and skin seen in new-born babies. The condition occurs due to high levels of bilirubin. Some of the common treatments of this disease include light therapy, intravenous immunoglobulin and exchange transfusion.
- Severe jaundice may even increase the risk of bilirubin passing into the brain that could result in permanent brain damage. Data Bridge Market Research analyses that neonatal jaundice treatment market is expected to grow with a CAGR of 4.60% during the forecast period.
Neonatal Jaundice Treatment Market Dynamics
Prevalence of Neonatal Jaundice
The rise in prevalence of neonatal jaundice across the globe among babies acts as one of the major factor driving the growth of neonatal jaundice treatment market.
The increase in the technological advancements in the infant phototherapy devices accelerate the market growth.
The increase in the funding by the federal government to drive the adoption of these treatment further influence the market.
Increase in geriatric population
The increase in the number of child births rising the prevalence of neonatal jaundice is boosting the market growth.
Additionally, , advanced healthcare healthcare regulatory scenarios, surge in funding on healthcare infrastructure, high investment in research and development, and advanced healthcare healthcare regulatory scenarios positively affect the neonatal jaundice treatment market.
Furthermore, rise in number of neonatal clinics extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Additionally, surge in investments will further expand the neonatal jaundice treatment market’s growth rate in the future.
On the other hand, risk associated with the side effect of phototherapy treatment expected to obstruct market growth. Also, dearth of awareness among population is projected to challenge the neonatal jaundice treatment market in the forecast period of 2022-2029.
This neonatal jaundice treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the neonatal jaundice treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID--19 Impact on Neonatal Jaundice Treatment Market
The rise in the number of people suffering from COVID, and increase in its severity rate increases the occurrences of health complications. The demand for various neonatal jaundice treatment increased owing to the concerns regarding health of new-born babies. Also, an inclination towards an inclination towards home care services is being witnessed globally because of the concerns over the spread of COVID-19 infection.
- Delta Medical launched two new products associated with the detection and treatment of neonatal jaundice in October’2017. The products are beneficial for quick ongoing clinical examination of neonatal jaundice.
Global Neonatal Jaundice Treatment Market Scope and Market Size
The neonatal jaundice treatment market is segmented on the basis of type, technology, end user and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Primary Care
- Secondary Care
On the basis of type, the neonatal jaundice treatment market is segmented into primary care and secondary care.
- Light-Emitting Diode Light Sources
- Hospitals, Clinics
- Ambulatory Surgical Centers
- Home Users
On the basis of end user, the neonatal jaundice treatment market is segmented into hospitals, clinics, ambulatory surgical centers, home users and others.
- Direct Tender
- Retail Sales
- Third Party Distribution
On the basis of end user, the neonatal jaundice treatment market is segmented into direct tender, retail sales and third party distribution.
Neonatal Jaundice Treatment Market Regional Analysis/Insights
The neonatal jaundice treatment market is analysed and market size insights and trends are provided by country, type, technology, end user and distribution channel as referenced above.
The countries covered in the neonatal jaundice treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the neonatal jaundice treatment market because of the introduction of new products within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the rise in target population in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The neonatal jaundice treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for neonatal jaundice treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the neonatal jaundice treatment market. The data is available for historic period 2010-2020.
Competitive Landscape and Neonatal Jaundice Treatment Market Share Analysis
The neonatal jaundice treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to neonatal jaundice treatment market.
Some of the major players operating in the neonatal jaundice treatment market are tom Medical Corp, avihealthcare, GENERAL ELECTRIC COMPANY, Ibis Medical, Natus Medical Incorporated, Ningbo David Medical, Weyer GmbH, Signify Holding., nice Neotech Medical Systems Pvt. Ltd., Phoenix Medical Systems (P) Ltd, and Solarc Systems Inc., among others.